Critical Care Therapy Systems address the needs of immobile, critical care patients and their caregivers.

Clinically demonstrated, cost-effective therapies deliver positive pulmonary outcomes and help manage skin integrity.

A significant pulmonary complication in critical care affecting patient's mortality and morbidity is development of Acute Respiratory Distress Syndrom (ARDS). ARDS is a devastating inflammatory disease of the lung characterized by the sudden onset of pulmonary edema and respiratory failure, usually in the setting of other acute medical conditions resulting from direct or indirect injury.

(ARDSNET.org) Patient mortality associated with ARDS is estimated between 32% and 45%.(Gattinoni 2001) Clinical conditions sometimes associated with the development of ARDS include:

Direct lung injury (Ware 1994)

  • Pneumonia
  • Aspiration of gastric contents
  • Inhalation injury
  • Near drowning
  • Pulmonary contusion
  • Fat embolism

Indirect lung injury (Ware 1994)

  • Sepsis
  • Severe trauma
  • Acute pancreatitis
  • Cardiopulmonary bypass
  • Massive transfusions
  • Drug overdose

As its name implies, ARDS is a syndrome, or a condition defined by a group of signs and symptoms. In 1994, the American European Consensus Conference on ARDS established the following universal definitions intended for clinical and investigational application:

Acute Respiratory Distress Syndrome (Bernard 1994)

  • Acute onset
  • Oxygenation: A partial pressure of arterial oxygen to fractional inspired oxygen concentration ratio < 200mmHg (regardless of PEEP).
  • Bilateral pulmonary infiltrates on chest radiograph.
  • Pulmonary artery wedge pressure < 18mmHg or no clinical evidence of left atrial hypertension.